لقد اجتاحت روسيا أوكرانيا في 24 فبراير/شباط 2022. قفوا مع أوكرانيا وادعمونا في كفاحنا من أجل الحرية والديمقراطية في أوروبا.  قف مع أوكرانيا!  انضم إلينا
search
منصة السياحة الطبية رقم 1 منذ عام 2014

أفضل تشخيص شامل لأمراض القولون والمستقيم أطباء الجهاز الهضمي في تركيا - توب -24 أطباء

author
يلبي المحتوى سياسة التحرير Bookimed ويتم مراجعتها طبياً من قبل
فهد مولود - طبيب عام. حاصل على 4 جوائز علمية. خدم في غرب آسيا. رئيس الفريق الطبي الناطق بالعربية سابقا ومسؤول عن معالجة البيانات ودقة المحتوى الطبي حاليا.
Mustafa Solak
أخصائي الأورام السريرية
18سنة خبره ١٦ سنة
4.5
113 تقييمات
تركيا, إسطنبول
Hisar Intercontinental Hospital

Mustafa Solak

أخصائي الأورام السريرية
18سنة خبره ١٦ سنة

مصطفى سولاك ، دكتوراه في الطب ، هو طبيب تخرج من كلية الطب بجامعة هاسيتيب وأتم إقاماته في مستشفى شيشلي إتفال التعليمي والبحوث بإسطنبول ومنح الزمالة في معهد السرطان بجامعة هاسيتيب. وهو متخصص في سرطان الثدي وسرطان الخصية وسرطان المبيض وسرطان الرئة وسرطان الرأس والعنق وسرطان الجهاز الهضمي. وقد عمل أيضًا في مركز إم دي أندرسون للسرطان بجامعة تكساس ، ومستشفى كوروم للتدريب بجامعة هيتيت ، ومستشفى ميديكال بارك.

اقرأ المزيد
4.5
113 تقييمات
تكلفة استشارة الطبيب السعر عند الطلب
شد البطن $5676
جراحة الأنف (انظر عملية تجميل الأنف)
استئصال القرص $2800 - $4700
المزيد من الطرق العلاجية
Tarik Akar
أخصائي أمراض الجهاز الهضمي
20سنة خبره ١٦ سنة
4.5
113 تقييمات
تركيا, إسطنبول
Hisar Intercontinental Hospital

Tarik Akar

أخصائي أمراض الجهاز الهضمي
20سنة خبره ١٦ سنة

تخرج الدكتور طارق أكار من كلية جراح باشا للطب بجامعة اسطنبول عام 2000 وحصل على لقب "طبيب باطني" في عام 2004. وقد نشر 19 بحثًا دوليًا و 6 أوراق محلية و 25 عرضًا تقديميًا في المؤتمرات المحلية والدولية. تشمل مجالات اهتماماته الطبية Achalasia و ESD و ERCP و Zenker Diverticulum و Gastroparesis.

اقرأ المزيد
4.5
113 تقييمات
تكلفة استشارة الطبيب السعر عند الطلب
شد البطن $5676
جراحة الأنف (انظر عملية تجميل الأنف)
استئصال القرص $2800 - $4700
المزيد من الطرق العلاجية
Elnur Sahibov
أخصائي الأورام الإشعاعية
8سنة خبره ١٦ سنة
4.2
31 تقييمات
تركيا, إسطنبول
Emsey Hospital

Elnur Sahibov

أخصائي الأورام الإشعاعية
8سنة خبره ١٦ سنة

مرخص أخصائي علاج الأورام بالإشعاع مع 8 سنوات من التدريب الطبي ، بما في ذلك الدراسات الجامعية في كلية الطب بجامعة مرمرة (2004-2011) والتدريب المتخصص في علاج الأورام بالإشعاع في كلية الطب بجامعة مرمرة (2012-2016). التعليم السابق من مدرسة Sixteen Numbered Shirvan School (أذربيجان) الثانوية (1998-2004).

اقرأ المزيد
Dr Bahaeddin Tapkan
أخصائي أمراض الجهاز الهضمي
14سنة خبره ١٦ سنة
5.0
1 تقييم

Dr Bahaeddin Tapkan

أخصائي أمراض الجهاز الهضمي
14سنة خبره ١٦ سنة
تركيا, إسطنبول
Basari Hospital
Prof Dr Ozgur Kemik
أخصائي الأورام السريرية
27سنة خبره ١٦ سنة
4.4
14 تقييمات
تركيا, إسطنبول
Hermes Clinics

Prof Dr Ozgur Kemik

أخصائي الأورام السريرية
27سنة خبره ١٦ سنة
Dr. Prof Dr Ozgur Kemik is a senior oncologist specializing in cancer management using minimally invasive techniques. He is proficient in operations such as Removal of liver cancer, Liver transplant, and Gastric bypass among others. His expertise includes advanced laparoscopic surgery, lower gastrointestinal tract cancers, hepatobiliary cancers, cytoreductive surgery, and kidney transplantation. He is a member of several professional associations and has held significant leadership positions in his career.اقرأ المزيد
Murat Sarikaya
أخصائي أمراض الجهاز الهضمي
20سنة خبره ١٦ سنة
4.0
1 تقييم
تركيا, إسطنبول
Medipol Bahçelievler Hospital

Murat Sarikaya

أخصائي أمراض الجهاز الهضمي
20سنة خبره ١٦ سنة

Experience:

2022 - 

Medipol Bahçelievler

2021 - 2022

MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL

2018 - 2020

İSTİNYE UNIVERSITY FACULTY OF MEDICINE

2014 - 2020

TOKAT STATE HOSPITAL

2010 - 2010

BINGOL STATE HOSPITAL

 

Education:

2021

MEDIPOL UNIVERSITY, GASTROTEROLOGY

2018

İSTINYE UNIVERSITY, INTERNAL DISEASES USA

2014

ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY

2010

FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT

2004

FIRAT UNIVERSITY, FACULTY OF MEDICINE

 

A. International Peer-Reviewed Journal Articles:

Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.

  • Authors: Sarıkaya Murat, Koçak Erdem, Köklü Seyfettin, Babalı Ayşegül, Çakal Başak
  • Journal: Acta Gastro-Enterologica Belgica
  • Year: 2012
  • Volume/Issue: (Kontrol No: 1206043)

Title: Acute gastric obstruction resulting from gallstone-induced bezoar.

  • Authors: Sarıkaya Murat, Koçak Erdem, Köklü Seyfettin, Akbal Erdem
  • Journal: The American Surgeon
  • Year: 2012
  • Volume/Issue: 78(12)
  • Page: 529
  • (Kontrol No: 1129707)

Title: Garlic-induced esophagitis.

  • Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
  • Journal: Acta Gastro-Enterologica Belgica
  • Year: 2013
  • Volume/Issue: 76(2)
  • Page: 262
  • (Kontrol No: 1131422)

Title: Association between Helicobacter pylori and liver-to-spleen ratio.

  • Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
  • Journal: European Journal of Gastroenterology & Hepatology
  • Year: 2013
  • Volume/Issue: 25(1)
  • Pages: 107-110
  • Citations: 7
  • DOI: 10.1097/MEG.0b013e3283590c10
  • (Kontrol No: 1131424)

Title: Crohn's disease masked by median arcuate ligament syndrome.

  • Authors: Bıyıkoğlu İbrahim, Sarıkaya Murat, Uysal Ramadan Selma, Ergül Bilal, Doğan Zeynal
  • Journal: Chinese Medical Journal
  • Year: 2013
  • Volume/Issue: 126 (14)
  • Page: 2798
  • Citations: 1
  • (Kontrol No: 1131477)

Title: Telaprevir and anemia: What we learned from the first three patients.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
  • Journal: Scandinavian Journal of Infectious Diseases
  • Year: 2013
  • Volume/Issue: 45(7)
  • Page: 575-575
  • Citations: 2
  • DOI: 10.3109/00365548.2012.759271
  • (Kontrol No: 1129738)

Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.

  • Authors: Sarıkaya Murat, Filik Levent, Ergul Bilal, Doğan Zeynal
  • Journal: Gastroenterology Nursing
  • Year: 2013
  • Volume/Issue: 36 (2)
  • Pages: 145-148
  • DOI: 10.1097/SGA.0b013e31828d3753
  • (Kontrol No: 1129715)

Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?

  • Authors: Ergül Bilal, Sarıkaya Murat, Doğan Zeynal, Filik Levent, Bıyıkoğlu İbrahim
  • Journal: Digestive Endoscopy
  • Year: 2013
  • Volume/Issue: 25(1)
  • Pages: 90-91
  • Citations: 2
  • DOI: 10.1111/j.1443-1661.2012.01383.x
  • (Kontrol No: 1129879)

Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.

  • Authors: Sarıkaya Murat, Filik Levent, Doğan Zeynal, Ergül Bilal
  • Journal: Gastroenterology Nursing
  • Year: 2013
  • Volume/Issue: 36(2)
  • Pages: 141-144
  • DOI: 10.1097/SGA.0b013e31828d33db
  • (Kontrol No: 1129712)

Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."

  • Authors: Bilal Ergül, Murat Sarıkaya, Zeynal Doğan, Sevda İdil, Tarkan Karakan, Abdullah Çetin Köseoğlu
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 725434
  • DOI: 10.1155/2013/725434
  • (Kontrol No: 1131423)

Title: Severe acute pancreatitis due to hypertriglyceridemia.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Bıyıkoğlu İbrahim
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 945902
  • DOI: 10.1155/2013/945902
  • (Kontrol No: 1131425)

Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Sevda İdil
  • Journal: Case Reports in Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 652960
  • DOI: 10.1155/2013/652960
  • (Kontrol No: 1131426)

Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 604820
  • DOI: 10.1155/2013/604820
  • (Kontrol No: 1131427)

Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
  • Journal: Turkish Journal of Gastroenterology
  • Year: 2013
  • Volume/Issue: 24(3)
  • Pages: 276-280
  • DOI: 10.4318/tjg.2013.0565
  • (Kontrol No: 1129727)

Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Tarkan Karakan
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 658370
  • DOI: 10.1155/2013/658370
  • (Kontrol No: 1131475)

Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 925259
  • DOI: 10.1155/2013/925259
  • (Kontrol No: 1131476)

B. Contributions to Scientific Conferences:

Title: Suicidal poisonings in Turkey: demographic and clinical aspects.

  • Authors: Sarikaya M., Gunes A., Goksu E., Erdogan G., Ozen C., Kaya A.
  • Conference: 30th European Congress of Clinical Toxicology (EAPCCT)
  • Year: 2000
  • Abstract ID: P44
  • (Kontrol No: 1131478)

Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.

  • Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
  • Conference: World Congress of Gastroenterology
  • Year: 2013
  • Abstract ID: P1367
  • (Kontrol No: 1131479)
اقرأ المزيد
4.0
1 تقييم
تكلفة استشارة الطبيب السعر عند الطلب
$10000 - $15000
العلاج الكيميائي
رأب الجفن $4000
المزيد من الطرق العلاجية
Nese Guney
أخصائي الأورام السريرية
26سنة خبره ١٦ سنة

Nese Guney

أخصائي الأورام السريرية
26سنة خبره ١٦ سنة
تركيا, إسطنبول
Biruni University Hospital
Omer Necip Aytug
أخصائي أمراض الجهاز الهضمي
44سنة خبره ١٦ سنة
4.5
113 تقييمات
تركيا, إسطنبول
Hisar Intercontinental Hospital

Omer Necip Aytug

أخصائي أمراض الجهاز الهضمي
44سنة خبره ١٦ سنة
ولد هذا الطبيب عام 1956 وتخرج من كلية الطب بجامعة هاسيتيب عام 1980. وحصل على لقب طبيب باطني عام 1985 وأكمل زمالة أمراض الجهاز الهضمي في جامعة مرمرة عام 1997. وكان أستاذًا مشاركًا في جامعة فرات منذ عام 1989 و أستاذ في جامعة أبانت عزت بايسال منذ عام 1998. عمل ودرّس في مستشفيات خاصة ، بما في ذلك مستشفى كامليكا ميديكانا ومستشفى ميموريال سيرفيس ، وكذلك كلية الطب بجامعة دوزجي.اقرأ المزيد
4.5
113 تقييمات
تكلفة استشارة الطبيب السعر عند الطلب
شد البطن $5676
جراحة الأنف (انظر عملية تجميل الأنف)
استئصال القرص $2800 - $4700
المزيد من الطرق العلاجية
Tolga Sahin
أخصائي أمراض الجهاز الهضمي
14سنة خبره ١٦ سنة
5.0
14 تقييمات
تركيا, إسطنبول
Group Florence Nightingale Hospitals

Tolga Sahin

أخصائي أمراض الجهاز الهضمي
14سنة خبره ١٦ سنة

الاعتمادات:

The International Liver Transplantation Society

Education: 

 

Akdeniz University Faculty of Medicine 

 

Specialization Training: 

 

Baskent University Faculty of Medicine. Internal diseases 

Akdeniz University Faculty of Medicine, Gastroenterology Minor 

 

Worked Institutions: 

Tekirdag State Hospital (Compulsory Service) 

Demiroğlu Bilim University Faculty of Medicine, Gastroenterology 

 

Medical Interests: 

 

Endoscopy-Colonoscopy 

ERCP 

Hepatology 

Inflammatory Bowel Diseases 

Liver Transplantation

اقرأ المزيد
Irfan Koruk
أخصائي أمراض الجهاز الهضمي
27سنة خبره ١٦ سنة
5.0
14 تقييمات

Irfan Koruk

أخصائي أمراض الجهاز الهضمي
27سنة خبره ١٦ سنة
تركيا, إسطنبول
Group Florence Nightingale Hospitals
Zulfu Sertkaya
أخصائي الأورام السريرية
16سنة خبره ١٦ سنة

Zulfu Sertkaya

أخصائي الأورام السريرية
16سنة خبره ١٦ سنة
تركيا, إسطنبول
Andro Expertise Clinic
Muhammed Gomec
جراح القولون والمستقيم
15سنة خبره ١٦ سنة
5.0
1 تقييم

Muhammed Gomec

جراح القولون والمستقيم
15سنة خبره ١٦ سنة
تركيا, Sivas
Medicana Sivas Hospital
Erol Cakmak
أخصائي أمراض الجهاز الهضمي
27سنة خبره ١٦ سنة
5.0
1 تقييم

Erol Cakmak

أخصائي أمراض الجهاز الهضمي
27سنة خبره ١٦ سنة
تركيا, Sivas
Medicana Sivas Hospital
Nail Paksoy
أخصائي الأورام / أخصائي الثدي
13سنة خبره ١٦ سنة
4.0
1 تقييم
تركيا, إسطنبول
Medipol Bahçelievler Hospital

Nail Paksoy

أخصائي الأورام / أخصائي الثدي
13سنة خبره ١٦ سنة

الاعتمادات:

ESMO Board Certification in Medical Oncology


PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

 

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

 

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

  • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
  • Role: Subinvestigator

2. PFİZER

  • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
  • Role: Subinvestigator

3. RECITE - AMGEN

  • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
  • Role: Subinvestigator

4. NAVIGATE - BAYER

  • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
  • Role: Subinvestigator

5. RUBY - Tesaro (PRA)

  • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
  • Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

  • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
  • Role: Subinvestigator

7. ASTRA ZENECA

  • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
  • Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

  • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
  • Role: Subinvestigator
  •  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
  • Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
  • Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

  • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
  • Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

  • Authors: Paksoy, Nail, et al.
  • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

  • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
  • Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

  • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
  • Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

  • Authors: HAS SIMSEK, Duygu, et al.
  • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

  • Authors: FERHATOGLU, Ferhat, et al.
  • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

  • Authors: GÜRBÜZ, Mustafa, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

  • Authors: AY, Seval, et al.
  • Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

  • Authors: CIL, Ibrahim, et al.
  • Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

  • Authors: HIZAL, Mutlu, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
  • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
  • Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

  • Authors: DEMIR, Semra, et al.
  • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

  • Authors: ÖZDEMIR, Seçil Kepil, et al.
  • Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

  • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
  • Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

  • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
  • Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
  • Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
  • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

  • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
  • Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

  • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
  • Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

  • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
  • Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

  • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
  • Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

  • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
  • Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

 

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

  • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

  • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

  • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

  • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

  • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

  • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

  • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

  • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

 

 

اقرأ المزيد
4.0
1 تقييم
تكلفة استشارة الطبيب السعر عند الطلب
$10000 - $15000
العلاج الكيميائي
رأب الجفن $4000
المزيد من الطرق العلاجية
Nihat Okcu
أخصائي أمراض الجهاز الهضمي
25سنة خبره ١٦ سنة
تركيا, إسطنبول
Medipol University Pendik Hospital

Nihat Okcu

أخصائي أمراض الجهاز الهضمي
25سنة خبره ١٦ سنة

Gastroenterology

 

Pendik Medipol University Hospital

 

 

Education

 

1999 Karadeniz Technical University, Gastroenterology

 

1997Atatürk University, Internal Diseases Professorship

 

1992 Atatürk University, Internal Diseases Associated Professorship 

 

1985 Atatürk University, Internal Diseases Specialist 

 

1981 Atatürk University Faculty of Medicine

 

 

Publications

1- Nihat Okçu Gülçin Polat,Arif Yılmaz,Mehmet Koruk,The demographıc features of gastrıc cancers ın erzurum(Eurasian J Med 2000; 32: 63-65)

 

2- Üst Gastrointestinal Kanamalı Olguların Bir Değerlendirilmesi. Klinik Bilimler-Doktor.2000, - E.akarsu,N.Okçu, ve Ark.Kuzeydoğu Anadolu’da 6:4:435-438

 

3-N.Okçu, A.yılmaz. İ.kiki,M.D.onuk, C.gündoğdu, H.uzunismail. Tanısal Üst Gastrointestinal endoskopi Sonuçlarımız. Atatürk Üniversitesi Tıp Dergisi 1997,29 (2):486

 

4-N. Okçu, M.gündoğdu, M.D. onuk, İ.kiki, l.cerrahoğlu, k.yılmaz, i. çapoğlu. Nonsteroid Anti İnflamatuar İlaç (NSAİİ) Kullanan Hastalarda oluşan Gastroduodenal Lezyonların Önlenmesinde Misoprostolün Yeri. Atatürk Üniversitesi Tıp Dergisi 1997,29 (2):453-455.

 

5-N.Okçu, A. öz, m.d. onuk, e.akarsu, b. tekin, h.z. tonbul, h.kaya. Kronik Aktif Hepatit İle Dekopanse Karaciğer Parankim Yetmezliğinde Plazma Fibronektin Düzeyleri ve Karaciğerin Fonksiyon Durumu İle İlişkisi. Türk J. Gastroenterol 1995;27(4): 422-426.

 

6-N.Okçu, tahir buran,m.d. onuk,a. yılmaz, e.akarsu, g. akçay. Erzurum ve Çevresinde Duodenum Ülserli Hastalarda Helicobacter Pylori Prevelansı. Türk J. Gastroenterol 1995;27(4): 447-450.

 

7-N.Okçu, b.s. uyanık, e. akarsu, e. bakan, z. tonbul. Mide ve Kolorektal Kanserlerinde Karbonhidrat Antijenleri (CA-19-9, CA-125), Karsinoembriyonik Antijen (CEA) ve Alkalen Fosfatazın Önemi. Türk J. Gastroenterol 1995;6:467-471.

 

8-N. Okçu, m.d. onuk, e. akarsu, h. doğan, c. gündoğdu. Bölgemizdeki Hepatoselüler Karsinomlu Hastalarda Major Risk Faktörleri. Gastroenteroloji 1994;5(2):154-157

 

9-N.Okçu, m.d. onuk, e. akarsu, h. doğan, c.gündoğdu, tahir buran. Erzurum Bölgesinde Gastrik Karsinom Sıklığı, Endoskopik ce Histolojik Özellikler. Gastroenteroloji 1994;5(2):263-267.

 

10-N. Okçu, m.d. onuk, tahir buran, e. akarsu, m.a. çiftçioğlu. Erzurum İli Çevresinde Nonspesifik Gastritli Olgularda Helicobacter Pylori Sıklığı. Gastroenteroloji 1994;5(2):211-213.

 

11-N.Okçu, m.d. onuk, ö. ünal, e. akarsu, l. incesu, k. akgöz. Karın İçi Kitle Lezyonlarında Ultrason Rehberliğinde Yapılan İnce İğne Aspirasyon Biyopsisinin Tanı Değeri. Gastroenteroloji 1993;4(1):166-68.

 

12-N.O.kçu, m.d. onuk, m. polat, a. yılmaz, m. gündoğdu, m. paç. Budd-Chiari Sendromu (2 Olgu). Türk J Gastroenterhepatol 1993; 4(1):77-80.

 

13-N.Okçu, h. koçak, m.d. onuk, m. gündoğdu, e. bakan, a. yılmaz, a. başoğlu, a. ateş, f.a. paç. The Effect of Atrial Pressure Changes and Cardiac Nerves on Plasma Atrial Natriüretic Peptide (ANP) Levels. Vascular Surgery 1993; 27(2): 128-132

 

15-N.Okçu, m.d. onuk, a.yılmaz, m. gündoğdu, t. buran. Omeprozol ve Ranitidinin Peptik Ülser İyileşmesine Etkileri. Doğa-Tr.J. of Medical Sciences 1992;16:657-658.

 

16-N. Okçu, m.r. yiğitoğlu, b. adam, e. bakan. Konjestif Kalp Yetersizliği Olan Hastalarda Digıxin’in Plazma Atrial Natriüretik Peptik Düzeyine Etkisi. S.Ü. Tıp Fak. Dergisi 1991;7(2):243-247..

 

17-N.Okçu, a. yılmaz. Üst Gastrointestinal Sistem Kanamalarında Histamin H2 -Reseptör Antagonistlerinin Etkisi. Endoskopi Dergisi 1991;2(4):17-23.

 

18-N.Okçu, E. bakan, b. adam, a. yılmaz, m.r. yiğitoğlu. Kronik Hepatit ve Karaciğer Sirozlu Hastalarda Seks Hormanları ve Seks Hormon Bağlayıcı Globülin Seviyeleri (Editöre Mektup). Doğa-Tr. J. Of Medical Sciences 1991;15:1-2.

 

19-N.Okcu Ömer Yılmaz.Helıcobacter pylorı and related gastroıntestınal system dıseases Turkiye Klinikleri JMed Sci. 2013;33(3):806-13

 

20-Nihat Okçu , Ömer yılmaz, hakan dursun, gülçin polat. Dispeptik semptomlarla beslenme alışkanlıkları, endoskopik ve histolojik bulgular arasındaki ilişki (Eurasian J Med 2006; 38: 13-17)

 

21-Mehmet Bilici,1Nihat Okcu,1Kerim Cayır,1Ibrahim Pirim,2Salim B. Tekin,1andCemal Gundogdu3 - Distribuion of HLA Tissue Groups in Patients with Gastric Cancer Eurasian J Med. 2010 Apr; 42(1): 9.11.

 

22-Nihat Okcu,Abdulhalim Bak,Mehmet Sari,Mehmet Arslan,Sait Kapicioglu :The fibroblast proliferation,relationship of hepatocyte growth factor (HGF) and interferon-A2A Gastroenterology April 2000Volume 118,Issue 4, Part 2, PageA1404

 

23-Kubra Kaynar,Sait Kapicioglu,Mehmet Sarı,Nihat Okcu,Abdulhalim Baki. The effect of fish oil on stress ulcer prophylaxis GastroenterologyVolume 118, Issue 4, Part 2, PageA1255

اقرأ المزيد
Hamza Ugur Bozbey
أخصائي الأورام السريرية
10سنة خبره ١٦ سنة

Hamza Ugur Bozbey

أخصائي الأورام السريرية
10سنة خبره ١٦ سنة
تركيا, إسطنبول
Uniqacare Clinic
Mehmet Altan Kaya
جراح عام
34سنة خبره ١٦ سنة
تركيا, إسطنبول
Grand Clinic

Mehmet Altan Kaya

جراح عام
34سنة خبره ١٦ سنة

UNIVERSITY

Ankara University Faculty of Medicine 

 

UNIVERSITY WHERE HE TAKES EXPERTISE

Göztepe Training and Research Hospital General Surgery

 

CONGRESSES ATTENDED

National Endoscopic Laparoscopic Surgery Congress

World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension

Bariatric and Metabolic Surgery Congress

Cerrahpaşa Surgery Meetings Turkish Bariatric Surgery Association

اقرأ المزيد
تكلفة استشارة الطبيب السعر عند الطلب
جراحة رفع الثدي $4830.68 - $6440.91
جراحة الأنف (انظر عملية تجميل الأنف) $2683.71 - $4293.94
شفط الدهون $2683.71 - $4293.94
المزيد من الطرق العلاجية
Abdulkerim Yilmaz
أخصائي أمراض الجهاز الهضمي
33سنة خبره ١٦ سنة
5.0
1 تقييم

Abdulkerim Yilmaz

أخصائي أمراض الجهاز الهضمي
33سنة خبره ١٦ سنة
تركيا, Sivas
Medicana Sivas Hospital
Yusuf Serdar Sakin
أخصائي أمراض الجهاز الهضمي
22سنة خبره ١٦ سنة
2.0
0 تقييم
تركيا, أنقرة
Private Koru Ankara Hospital

Yusuf Serdar Sakin

أخصائي أمراض الجهاز الهضمي
22سنة خبره ١٦ سنة

Prof. M.D. Yusuf Serdar Sakin was born in Nevşehir in 1978. After completing his primary and secondary education in Ankara, he graduated from the Faculty of Medicine at Gülhane Military Medical Academy in 2002.
Following his graduation, he served in Gole/Ardahan for two years. He started his internal medicine training at the Department of Internal Medicine, Gülhane Faculty of Medicine.
After completing his training, he worked as an internal medicine specialist in Ankara. A year later, he began additional training in the Department of Gastroenterology at Gülhane Faculty of Medicine and completed his training in 2014.
After graduation, Yusuf Serdar Sakin continued to work in the same department. He also received advanced endoscopy and Motility training at AMC Center in the Netherlands in 2017.
After obtaining the title of Associate Professor in 2017, he became a Professor in 2023.
He currently provides medical services to patients at Koru Ankara Hospital. His areas of medical interest include:

-Endoscopic retrograde cholangiopancreatography (ERCP)
-Push enteroscopy
-Endoscopic mucosal resection
-High-resolution manometry
-pH/pH-impedance metry analysis
-Advanced endoscopic procedures (stenting, dilation, etc.)
-Gastrointestinal motility disorders
-Gastroesophageal reflux disease
-Inflammatory bowel diseases
-Advanced endoscopic procedures and pancreatitis.

اقرأ المزيد
Ahmet Burak Toros
أخصائي أمراض الجهاز الهضمي
22سنة خبره ١٦ سنة
5.0
1 تقييم
تركيا, إسطنبول
Medistate Hospital Istanbul

Ahmet Burak Toros

أخصائي أمراض الجهاز الهضمي
22سنة خبره ١٦ سنة

https://www.medistate.com.tr/en/physicians/ahmet-burak-toros

اقرأ المزيد